Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: July 2015

12 - Cushing’s syndrome in females

from Section 3 - Learning from the extremes
1.Newell-Price, J, Bertagna, X, Grossman, AB, Nieman, LK. Cushing’s syndrome. Lancet 2006;367(9522):16051617.
2.Goodwin, S, Silverstein, J. Cushing’s syndrome. In: Henderson, KE, ed. The Washington Manual Endocrinology Subspecialty Consult. 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2009.
3.Hopkins, RL, Leinung, MC. Exogenous Cushing’s syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am 2005;34(2):371384, ix.
4.Villanueva, RB, Brett, E, Gabrilove, JL. A cluster of cases of factitious Cushing’s syndrome. Endocr Pract 2000;6(2):143147.
5.Cushing, H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. Obes Res 1994;2(5):486508.
6.Alexandraki, KI, Grossman, AB. The ectopic ACTH syndrome. Rev Endocr Metab Disord 2010;11(2):117126.
7.Kirschner, LS, Carney, JA, Pack, SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the carney complex. Nat Genet 2000;26(1):8992.
8.Groussin, L, Jullian, E, Perlemoine, K, et al. Mutations of the PRKAR1A gene in Cushing’s syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 2002;87(9):43244329.
9.Weinstein, LS, Shenker, A, Gejman, PV, Merino, MJ, Friedman, E, Spiegel, AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325(24):16881695.
10.Lindholm, J, Juul, S, Jorgensen, JO, et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab 2001;86(1):117123.
11.Etxabe, J, Vazquez, JA. Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994;40(4):479484.
12.Bolland, MJ, Holdaway, IM, Berkeley, JE, et al. Mortality and morbidity in Cushing’s syndrome in New Zealand. Clin Endocrinol (Oxf) 2011;75(4):436442.
13.Terzolo, M, Pia, A, Reimondo, G. Subclinical Cushing’s syndrome: definition and management. Clin Endocrinol (Oxf) 2012;76(1):1218.
14.Catargi, B, Rigalleau, V, Poussin, A, et al. Occult Cushing’s syndrome in type-2 diabetes. J Clin Endocrinol Metab 2003;88(12):58085813.
15.Chiodini, I, Torlontano, M, Scillitani, A, et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 2005;153(6):837844.
16.Leibowitz, G, Tsur, A, Chayen, SD, et al. Pre-clinical Cushing’s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf) 1996;44(6):717722.
17.Chiodini, I, Mascia, ML, Muscarella, S, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 2007;147(8):541548.
18.Chiodini, I, Morelli, V, Masserini, B, et al. Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 2009;94(9):32073214.
19.Newell-Price, J, Trainer, P, Besser, M, Grossman, A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998;19(5):647672.
20.Zilio, M, Barbot, M, Ceccato, F, et al. Diagnosis and complications of Cushing’s disease: gender-related differences. Clin Endocrinol (Oxf) 2014;80(3):403410.
21.Storr, HL, Isidori, AM, Monson, JP, Besser, GM, Grossman, AB, Savage, MO. Prepubertal Cushing’s disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 2004;89(8):38183820.
22.Pecori Giraldi, F, Moro, M, Cavagnini, F, Study Group on the Hypothalamo-Pituitary-Adrenal Axis of the Italian Society of Endocrinology. Gender-related differences in the presentation and course of Cushing’s disease. J Clin Endocrinol Metab 2003;88(4):15541558.
23.Chaidarun, SS, Swearingen, B, Alexander, JM. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. J Clin Endocrinol Metab 1998;83(9):33083315.
24.Cushing’s disease and syndrome. In: Jones, H, Scott, W, eds. Hermaphroditism, Genital Anomalies and Related Endocrine Disorders. 2nd edition. Chapter 24. Baltimore: The Williams & Wilkins Company, 1971; 491–506
25.Nieman, LK, Biller, BM, Findling, JW, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008;93(5):15261540.
26.Nugent, CA, Warner, HR, Dunn, JT, TYLER FH. Probability theory in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 1964;24:621627.
27.Pecori Giraldi, F, Pivonello, R, Ambrogio, AG, et al. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf) 2007;66(2):251–257.
28.Ross, EJ, Linch, DC. Cushing’s syndrome–killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 1982;2(8299):646649.
29.Arnaldi, G, Angeli, A, Atkinson, AB, et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 2003;88(12):55935602.
30.Dekkers, OM, Horvath-Puho, E, Jorgensen, JO, et al. Multisystem morbidity and mortality in Cushing’s syndrome: a cohort study. J Clin Endocrinol Metab 2013;98(6):22772284.
31.Graversen, D, Vestergaard, P, Stochholm, K, Gravholt, CH, Jorgensen, JO. Mortality in Cushing’s syndrome: a systematic review and meta-analysis. Eur J Intern Med 2012;23(3):278282.
32.Hassan-Smith, ZK, Sherlock, M, Reulen, RC, et al. Outcome of Cushing’s disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab 2012;97(4):11941201.
33.Clayton, RN, Raskauskiene, D, Reulen, RC, Jones, PW. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 2011;96(3):632642.
34.Barahona, MJ, Sucunza, N, Resmini, E, et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. J Clin Endocrinol Metab 2009;94(9):33653371.
35.Geer, EB, Shen, W, Strohmayer, E, Post, KD, Freda, PU. Body composition and cardiovascular risk markers after remission of Cushing’s disease: a prospective study using whole-body MRI. J Clin Endocrinol Metab 2012;97(5):17021711.
36.Pecori Giraldi, F, Ambrogio, AG, De Martin, M, Fatti, LM, Scacchi, M, Cavagnini, F. Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J Clin Endocrinol Metab 2007;92(11):41234129.
37.Carroll, T, Raff, H, Findling, JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract 2009;15(4):335342.
38.Nieman, L. Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing’s syndrome: what have we learned in 14 years? J Clin Endocrinol Metab 2007;92(8):28762878.
39.Elamin, MB, Murad, MH, Mullan, R, et al. Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 2008;93(5):15531562.
40.Read, GF, Walker, RF, Wilson, DW, Griffiths, K. Steroid analysis in saliva for the assessment of endocrine function. Ann NY Acad Sci 1990;595:260274.
41.Doi, SA, Clark, J, Russell, AW. Concordance of the late night salivary cortisol in patients with Cushing’s syndrome and elevated urine-free cortisol. Endocrine 2013;43(2):327333.
42.Baid, SK, Sinaii, N, Wade, M, Rubino, D, Nieman, LK. Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J Clin Endocrinol Metab 2007;92(8):31023107.
43.Qureshi, AC, Bahri, A, Breen, LA, et al. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol (Oxf) 2007;66(5):632635.
44.Invitti, C, Pecori, Giraldi F, de Martin, M, Cavagnini, F. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. study group of the Italian Society of Endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 1999;84(2):440448.
45.Aron, DC, Raff, H, Findling, JW. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1997;82(6):17801785.
46.Nieman, LK, Oldfield, EH, Wesley, R, Chrousos, GP, Loriaux, DL, Cutler, GB, Jr. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1993;77(5):13081312.
47.de Keyzer, Y, Lenne, F, Auzan, C, et al. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 1996;97(5):13111318.
48.Biller, BM, Grossman, AB, Stewart, PM, et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 2008;93(7):24542462.
49.Dinsen, S, Baslund, B, Klose, M, et al. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med 2013;24(8):714720.
50.Young, WF, Jr, Thompson, GB. Laparoscopic adrenalectomy for patients who have Cushing’s syndrome. Endocrinol Metab Clin North Am 2005;34(2):489499, xi.
51.Assalia, A, Gagner, M. Laparoscopic adrenalectomy. Br J Surg. 2004;91(10):12591274.
52.Dekkers, OM, Biermasz, NR, Pereira, AM, et al. Mortality in patients treated for Cushing’s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2007;92(3):976981.
53.Rees, DA, Hanna, FW, Davies, JS, Mills, RG, Vafidis, J, Scanlon, MF. Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 2002;56(4):541551.
54.Assie, G, Bahurel, H, Coste, J, et al. Corticotroph tumor progression after adrenalectomy in Cushing’s disease: a reappraisal of nelson’s syndrome. J Clin Endocrinol Metab 2007;92(1):172179.
55.Jenkins, PJ, Trainer, PJ, Plowman, PN, et al. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 1995;80(1):165171.
56.Ding, D, Starke, RM, Sheehan, JP. Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy. J Neurooncol 2013; 117(3):445457.
57.Jagannathan, J, Sheehan, JP, Pouratian, N, Laws, ER, Steiner, L, Vance, ML. Gamma knife surgery for Cushing’s disease. J Neurosurg 2007;106(6):980987.